In a large group of patients with metastatic colorectal cancer, consuming a few cups of coffee a day was associated with more prolonged survival and a lower risk of cancer worsening. Researchers at Dana-Farber Cancer Institute and other organizations report in a new study.

Based on data from a large observational study nested in a clinical trial, the findings are in line with earlier studies showing a connection between regular coffee consumption and improved outcomes in patients with non-metastatic colorectal cancer. The course is being published today by JAMA Oncology.